RELMADA THERAPEUTICS, INC. — Director's Dealing 2019

Oct 21, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RELMADA THERAPEUTICS, INC. (RLMD)
CIK: 0001553643
Period of Report: 2019-10-18

Reporting Person: Kelly Paul Edward (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-10-18	Common Stock	P	1000	$18.99	Acquired	123121	Direct
2019-10-18	Common Stock	P	100	$19.04	Acquired	123221	Direct
2019-10-18	Common Stock	P	400	$19.07	Acquired	123621	Direct
2019-10-18	Common Stock	P	100	$19.08	Acquired	123721	Direct
2019-10-18	Common Stock	P	200	$19.10	Acquired	123921	Direct
2019-10-18	Common Stock	P	100	$19.15	Acquired	124021	Direct
2019-10-18	Common Stock	P	3100	$19.20	Acquired	127121	Direct